Abstract:Abstract Background Pyrrolidine alkaloid‑induced hepatic sinusoidal obstruction syndrome (PA-HSOS) is a drug-induced liver injury characterized by sudden and rapidly progressive portal hypertension. Hepatic venous pressure gradient (HVPG) is the gold standard for the diagnosis of sinus hypertension, at least in viral and alcoholic liver disease, while its role in evaluating disease severity and treatment choice and predicting prognosis in patients with PA-HSOS needs further verification. The aim of this study was to investigate the clinical value of HVPG in patients with PA-HSOS. Methods Patients who were diagnosed with PA-HSOS according to the “Nanjing criteria” and received HVPG measurements in our hospital between January 2016 and April 2020 were reviewed retrospectively. Next, the predictive efficacy of HVPG in initial anticoagulant therapy, the prognostic survival of patients in different HVPG groups, the relationship between HVPG and the Drum Tower Severity Scoring (DTSS), the correlation between HVPG and pathological data were all evaluated. Results A total of 76 PA-HSOS patients were included in the study. Multivariate logistic regression analysis identified HVPG as independently associated with nonresponse to initial anticoagulation (95% CI: 1.006-1.413, P=0.043). The receiver operating characteristic curve (ROC) identified a cutoff value of 20.165 mmHg (sensitivity: 0.744, specificity: 0.697) for predicting nonresponse to initial anticoagulation, and the area under the curve (AUC) was 0.741 (95% CI: 0.626-0.857, P<0.001). When HVPG>20.165 mmHg was combined with serum total bilirubin (STB), heart rate (HR) and blood urea nitrogen (BUN) for modeling, the AUC was 0.881 (P<0.001). Seventy-six patients were divided into two groups according to whether HVPG was greater than 20.165 mmHg, and the patients in the high HVPG group (HVPG＞20.165 mmHg) had a significantly worse prognostic survival than the patients in the low HVPG group (HVPG＜20.165 mmHg) (P=0.022, χ2=5.285). Additionally, there was a linear correlation between HVPG and the area of sinusoidal bleeding in 76 patients (P=0.008, R=0.343). Furthermore, after excluding the patients with an onset time of more than 1 month, HVPG improved the efficacy in predicting nonresponse to anticoagulant therapy (AUC=0.789, 95% CI: 0.654-0.924, P=0.001), and the linear relationship between HVPG and bleeding area in the sinusoids was enhanced (P=0.001, R=0.499). In addition, a linear relationship between HVPG and DTSS emerged (P<0.001, R=0.522). Conclusions HVPG can assist in predicting the outcome of anticoagulant therapy and prognosis in patients with PA-HSOS, and this prediction is more accurate for patients within one month of disease onset.

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension.

Direct Bilirubin: A New Risk Factor of Adverse Outcome in Idiopathic Pulmonary Arterial Hypertension

Effects of Bilirubin on Perioperative Myocardial Infarction and Its Long-Term Prognosis in Patients Undergoing Percutaneous Coronary Intervention

Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors.

Liver Dysfunction in Idiopathic Pulmonary Arterial Hypertension: Prevalence, Characteristics and Prognostic Significance, a Retrospective Cohort Study in China.

Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term Adverse Events in HFpEF

Effect of Direct Bilirubin Level on Clinical Outcome and Prognoses in Severely/Critically Ill Patients With COVID-19

Correlation between serum bilirubin levels and the severity as well as the prognosis of idiopathic pulmonary fibrosis

Association of direct bilirubin to total bilirubin ratio with 90-day mortality in patients with acute-on-chronic liver failure

Relation of Direct, Indirect, and Total bilirubin to Adverse Long-term Outcomes Among Patients With Acute Coronary Syndrome.

Different Effects of Total Bilirubin on 90-Day Mortality in Hospitalized Patients With Cirrhosis and Advanced Fibrosis: A Quantitative Analysis

Impact of Idiopathic Premature Ventricular Contraction on Apolipoprotein A1 and Bilirubin

Relationship Between Serum Bilirubin Levels and Mortality in Patients on Peritoneal Dialysis

The value of hepatic venous pressure gradient in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome

Direct Bilirubin Levels Predict Long-Term Outcomes in Patients With Acute Coronary Syndrome Under Different Glucose Metabolism Status: A 6.5-Year Cohort Study of Three-Vessel Disease

Bilirubin Levels as Potential Indicators of Disease Severity in Coronavirus Disease Patients: A Retrospective Cohort Study

[The Clinical Analysis of 18 Cases with Bilateral Lung Transplantation for Severe Idiopathic Pulmonary Arterial Hypertension].

Association of elevated baseline bilirubin caused by preadmission statin use with cardiovascular prognosis in patients undergoing elective percutaneous coronary intervention

Association between serum bilirubin concentration and Parkinson's disease: a meta-analysis

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry

Blood urea nitrogen to serum albumin ratio as a new indicator of disease severity and prognosis in idiopathic pulmonary artery hypertension